1-855-378-42281-855-378-4228
One of the out-patient rehab alternatives for individuals in Sylvania who are struggling with opioid dependence and addiction is opioid maintenance therapy. Licensed centers and doctors are certified to give specific meds to opioid addicted clients, many that are opioid-based themselves and are habit forming. In low doses the client doesn't experience being high and also does not have severe cravings and is not in opioid withdrawal. Methadone is the first medication administered for this purpose, but there are a few more choices to pick from.
Methadone is an opiate and can be taken at an out-patient clinic licensed to dispense the drug, which is taken on a daily basis in liquid or pill form. The price of the drug is around one hundred and fifty dolloars a month. Buprenorphine is also an opiate based med, and is a pill often taken one day on, one day off. But different from Methadone that is only be administered in well-regulated clinics, Buprenorphine can be prescribed and administered in doctor's offices. The cost monthly of buprenorphine is approximately three hundred dollars a month for the generic version of the medication. There is also a version of buprenorphine containing the drug naloxone, which is a med which reverses the effects of opioids. Someone taking this formulation, also known as Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and costs around $450 a month. Naltrexone is an additional medication taken in opioid maintenance therapy, but unlike the other medications aforementioned it is an opioid blocker and is not an opioid. A person has the choice to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, it prevents a person from getting high from opioids, and in turn lowers the risk associated with relapse. This daily injection costs in the range of $1000 to $1200 /month.
For All Drug and Alcohol Treatment Facilities In Sylvania, Click Here.
